Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWynnstay Regulatory News (WYN)

Share Price Information for Wynnstay (WYN)

Share Price is delayed by 15 minutes
Get Live Data
350.00    0.00 (0.00%)
Bid:
345.00
Ask:
355.00
Spread: 10.00 (2.899%)
Market Cap: £80.57m
WYN Live PriceLast checked at - London Stock Exchange

Intraday Wynnstay Share Chart

Changes to Employee Share Scheme and TVR

27 Feb 2025 13:57

RNS Number : 7591Y
Wynnstay Group PLC
27 February 2025
 

AIM: WYN

Wynnstay Group plc

("Wynnstay" or the "Company")

Changes to Employee Share Scheme and Total Voting Rights

 

Changes to Employee Share Scheme

On 26 February 2025, the Company's ESOP Trust (the "ESOP") sold its remaining 57,855 ordinary shares of 25 pence each in the Company ("Ordinary Shares") to The Wynnstay Employee Benefit Trust (the "EBT"), a replacement employees' share scheme under section 1166 of the Companies Act 2006 whose Trustees are Fiduchi Trustees Limited, a company incorporated in Jersey whose registered office is at Lime Grove House, Green Street, St Helier, Jersey JE2 4UB. No Directors of the Company will serve as Trustees of the EBT, and as a result the shares held by the EBT will not be deemed to be controlled by the Directors of the Company or Persons Discharging Managerial Responsibilities.

Following this transaction, the ESOP no longer holds any beneficial interest in the Company's Ordinary Shares.

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue is 23,127,360 with each share carrying the right to one vote. There are no shares held in treasury. Therefore, the total number of voting rights in the Company at Admission is 23,127,360.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

For further details please contact:

 

Wynnstay Group plc

Alk Brand, Chief Executive Officer

Rob Thomas, Chief Financial Officer

T: 01691 827118

 

KTZ Communication

Katie Tzouliadis / Robert Morton

T: 020 3178 6378

Shore Capital (Nomad)

Stephane Auton / Tom Knibbs (Corporate Advisory)

Henry Wilcocks (Corporate Broking)

 

 

 

T: 020 7408 4090

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

Wynnstay ESOP Trust

 

2

 

Reason for the notification

 

 

a)

 

Position/status

Company's ESOP Trust

 

b)

 

Initial notification /Amendment

 

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Wynnstay Group plc

 

 

b)

 

LEI

 

213800TOLA726AITR960

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 25 pence each in the Company ("Ordinary Shares")

 

GB0034212331

 

 

b)

 

Nature of the transaction

 

 

Sale of Ordinary shares of 25 pence each in the Company ("Ordinary Shares") to The Wynnstay Employee Benefit Trust under a Share Supply Agreement between Wynnstay Group Plc and Fiduchi Trustees Limited

 

 

 

 

c)

 

 

 

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£3.25

 

 

57,885 Ordinary Shares

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A single transaction

 

e)

 

Date of the transaction

26/02/2025

 

f)

 

Place of the transaction

 

 

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUWAPUPAGWM
Date   Source Headline
10th Jun 20267:00 amRNSNotice of HY Results & Investor Presentation
5th May 20262:31 pmRNSDirector and PDMR Shareholding
1st May 20267:00 amRNSAward of Options and Total Voting Rights
26th Mar 20263:31 pmRNSDirector/PDMR Shareholding
24th Mar 20265:11 pmRNSResult of AGM
24th Mar 20267:00 amRNSAGM Statement
2nd Mar 20267:00 amRNSBlock Listing Return
13th Feb 20263:30 pmRNSDirector/PDMR Shareholding
9th Feb 20264:40 pmRNSDividend timetable
9th Feb 20267:00 amRNSFinal Results
26th Jan 20267:00 amRNSNotice of Results and Investor presentation
29th Dec 202510:05 amRNSHolding(s) in Company
29th Dec 202510:05 amRNSHolding(s) in Company
1st Dec 202511:44 amRNSDirector/PDMR Share Purchases
1st Dec 20257:00 amRNSTrading Update
3rd Nov 20256:25 pmRNSDirector/PDMR Shareholding
6th Oct 20251:51 pmRNSDirector and PDMR dealing
24th Sep 20256:01 pmRNSDirector and PDMR dealing - Replacement
24th Sep 20253:50 pmRNSDirector and PDMR dealing
24th Sep 202512:05 pmRNSDirector and PDMR dealing
1st Sep 20257:00 amRNSBlock Listing Return
5th Aug 20255:10 pmRNSDirector Share Purchases
2nd Jul 20253:44 pmRNSPCA dealing
1st Jul 20252:20 pmRNSDirector Share Purchase
1st Jul 20257:00 amRNSInterim Results
16th Jun 20257:00 amRNSNotice of Results
2nd May 20257:00 amRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSDirector and PDMR dealing
30th Apr 202511:55 amRNSDirector/PDMR Shareholding
29th Apr 20254:22 pmRNSDirector and PDMR dealing
25th Apr 20253:04 pmRNSDirector/PDMR Shareholding
1st Apr 20259:26 amRNSDirector/PDMR Shareholding
27th Mar 20253:36 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Update
25th Mar 20257:00 amRNSBoard Appointments
3rd Mar 202511:28 amRNSBlock Listing Return
27th Feb 20251:57 pmRNSChanges to Employee Share Scheme and TVR
20th Feb 20252:46 pmRNSDirector Dealing and Total Voting Rights
18th Feb 20254:32 pmRNSExercise of Options and Total Voting Rights
13th Feb 20255:31 pmRNSExercise of Options and Total Voting Rights
13th Feb 202512:54 pmRNSHolding(s) in Company - TR-1 Notification
12th Feb 20255:39 pmRNSExercise of Options, Director Dealings and TVR
11th Feb 20256:42 pmRNSDirector/PDMR dealings, Award of Options, TVR
11th Feb 20255:59 pmRNSCorrection of record date for final dividend
11th Feb 20257:00 amRNSFinal Results
21st Jan 20257:00 amRNSNotice of Final Results
31st Oct 20247:00 amRNSScrip dividend election, PDMR Dealing, TVR
30th Oct 20244:47 pmRNSDirector/PDMR Shareholdings
23rd Oct 20244:35 pmRNSDirector/PDMR Shareholding
18th Oct 20244:28 pmRNSTR-1 Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.